Journal
NATURE
Volume 592, Issue 7853, Pages 180-183Publisher
NATURE PORTFOLIO
DOI: 10.1038/d41586-021-00870-x
Keywords
Neurodegeneration; Drug discovery; Genetics
Categories
Ask authors/readers for more resources
Drugs that silence faulty genes could potentially treat brain diseases, but a halted clinical trial has posed a setback in this field.
A class of drugs that silence the effects of faulty genes could help tackle brain diseases - but a halted clinical trial has brought the field up short.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
